Unfortunately, the NK-1R antagonist drugs netupitant, fosnetupitant, rolapitant, and tradipitant are currently only known for their antinausea and antivomiting activities and their antitumor activity in gliomas has not been studied to date. The gene discussed is TACR1; the disease is central nervous system cancer.